Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial

BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Alysha M., Okonkowski, Linda K., Brudvig, Jean M., Refsal, Kent R., Berghoff, Nora, Olivier, N. Bari, Langlois, Daniel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://www.ncbi.nlm.nih.gov/pubmed/34114259
http://dx.doi.org/10.1111/jvim.16195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://www.ncbi.nlm.nih.gov/pubmed/34114259
http://dx.doi.org/10.1111/jvim.16195

Ejemplares similares